{
    "Trade/Device Name(s)": [
        "OPTI CCA-TS B-Lac Cassette",
        "B-Lac Cassette",
        "OPTI CCA-Critical Care Analyzer"
    ],
    "Submitter Information": "OPTI Medical Systems, Inc.",
    "510(k) Number": "K093280",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061974"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CHL",
        "KHP",
        "GKR",
        "GLY"
    ],
    "Summary Letter Date": "December 21, 2010",
    "Summary Letter Received Date": "December 27, 2010",
    "Submission Date": "December 20, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.1120",
        "21 CFR 862.1450",
        "21 CFR 864.5620",
        "21 CFR 864.7500"
    ],
    "Regulation Name(s)": [
        "Blood gases (PCO2, PO2) and blood pH test system",
        "Lactic acid (enzymatic method) test system",
        "System, hemoglobin, automated",
        "Oximeter, whole blood"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "hematology"
    ],
    "Analyte(s)": [
        "pH",
        "PCO2",
        "PO2",
        "Lactate (lactic acid)",
        "Total hemoglobin (tHb)",
        "Oxygen saturation (SO2)"
    ],
    "Specimen Type(s)": [
        "Whole blood (arterial)",
        "Whole blood (venous)"
    ],
    "Specimen Container(s)": [
        "Heparinized syringe",
        "Heparinized capillary tube"
    ],
    "Instrument(s)/Platform(s)": [
        "OPTI CCA-TS analyzer system"
    ],
    "Method(s)/Technology(ies)": [
        "Optical fluorescence",
        "Enzymatic oxidation",
        "Laser-based measurement",
        "Optical reflectance"
    ],
    "Methodologies": [
        "Fluorescence optode measurement",
        "Lactate oxidase-based sensor"
    ],
    "Submission Type(s)": [
        "Cassette",
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for OPTI CCA-TS B-Lac cassette for measurement of pH, blood gases, lactate, total hemoglobin, and oxygen saturation in whole blood using fluorescence and enzymatic methods",
    "Indications for Use Summary": "For in vitro measurements of pH, PCO2, PO2, lactate (lactic acid), total hemoglobin, and oxygen saturation in heparinized whole blood (arterial or venous) on the OPTI CCA-TS system in clinical and point-of-care settings",
    "fda_folder": "Clinical Chemistry"
}